Gilead Sciences Inc. (GILD)
NASDAQ: GILD
· Real-Time Price · USD
116.67
-1.19 (-1.01%)
At close: Sep 12, 2025, 9:50 AM
-1.01% (1D)
| Bid | 116.63 |
| Market Cap | 144.77B |
| Revenue (ttm) | 28.86B |
| Net Income (ttm) | 6.31B |
| EPS (ttm) | 7.74 |
| PE Ratio (ttm) | 15.07 |
| Forward PE | 13.37 |
| Analyst | Buy |
| Ask | 116.69 |
| Volume | 466,512 |
| Avg. Volume (20D) | 6,808,006 |
| Open | 117.49 |
| Previous Close | 117.86 |
| Day's Range | 116.38 - 117.63 |
| 52-Week Range | 81.57 - 121.83 |
| Beta | 0.38 |
About GILD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GILD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GILD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Gilead Sciences Inc. is scheduled to release its earnings on
Nov 5, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.28%
Gilead Sciences shares are trading higher after th...
Unlock content with
Pro Subscription
1 month ago
+2.65%
Gilead Sciences shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a price target of $133.
